Learn More
Human Integrin alpha 4 beta 7/LPAM-1 (Research Grade Vedolizumab Biosimilar) PE-conjugated Antibody, R&D Systems™

Description
Specifications
Specifications
| Antigen | Integrin alpha 4 beta 7/LPAM-1 |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | Hu117 |
| Conjugate | PE |
| Dilution | Flow Cytometry 10 uL/10^6 cells |
| Formulation | Supplied in a saline solution containing BSA and Sodium Azide. |
| Gene Alias | 269C wild type, CD49 antigen-like family member D, CD49d, CD49d antigen, CD49d/beta7, CD49Dantigen CD49D, alpha-4 subunit of VLA-4 receptor, IA4, integrin alpha 4, integrin alpha-4, integrin alpha-4 subunit, Integrin alpha-IV, integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor), LPAM1, LPAM-1, MGC90518, very late activation protein 4 receptor, alpha 4 subunit, VLA-4 subunit alpha |
| Host Species | Human |
| Immunogen | Human Integrin alpha 4 beta 7/LPAM-1 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.